Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Shanghai Pharmaceuticals Holding patents Wee1-like protein kinase inhibitors

Jan. 20, 2021

ZM-32, a novel muscone derivative that inhibits breast tumor angiogenesis in vivo

Jan. 20, 2021

Dosing begins in phase I/II study of TP-0184 as treatment of anemia in patients with MDS

Jan. 20, 2021

CRY1 unveiled as a hormone-induced tumorigenic factor in prostate cancer

Jan. 19, 2021

New JAK inhibitors synthesized at Guangzhou Innocare Pharma Tech

Jan. 19, 2021

Guangdong Newopp Biopharmaceuticals identifies mutant KRAS inhibitors

Jan. 19, 2021

Hangzhou Hertz Pharmaceutical patents casein kinase 1 isoform epsilon inhibitors

Jan. 19, 2021

New CDK9/cyclin T1 inhibitors discovered at Medshine Discovery

Jan. 19, 2021

Enrollment opens in phase II study of vactosertib plus pembrolizumab in NSCLC

Jan. 19, 2021

BET inhibitors synergize with BCL-2 or HDAC inhibitors in Waldenstrom macroglobulinemia

Jan. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...